IV (Intravascular) Catheters Market By Product Type (Peripheral IV Catheters Billion in, Central Venous Catheters (CVCs), Midline Peripheral Catheters, Integrated/Closed IV Catheters), Material (Polyurethane IV Catheter, Silicone IV Catheters, Teflon IV Catheters), End-User (Hospitals Pharmacies, Retail Pharmacies), Region for 2024-2031

Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

IV (Intravascular) Catheters Market By Product Type (Peripheral IV Catheters Billion in, Central Venous Catheters (CVCs), Midline Peripheral Catheters, Integrated/Closed IV Catheters), Material (Polyurethane IV Catheter, Silicone IV Catheters, Teflon IV Catheters), End-User (Hospitals Pharmacies, Retail Pharmacies), Region for 2024-2031

IV (Intravascular) Catheter Market Valuation – 2024-2031

The increasing focus on self-care and home-based healthcare is driving the demand for IV catheters that are user-friendly for patients to use outside of clinical settings. As more patients manage their care and self-administer medications at home, there is a growing need for IV catheters designed for ease of use in non-clinical environments. Thus, the growth in self-care and home-based healthcare surged the growth of market size surpassing USD 8.92 Billion in 2024 to reach a valuation of USD 17.49 Billion by 2031.

The rising number of surgical procedures performed in hospitals and ambulatory surgical centers is contributing to the market’s expansion. The need for IV catheters is heightened for perioperative and postoperative treatments, as they play a crucial role in administering fluids, medications, and nutrients during and after surgeries. This increase in surgical activity is driving demand for a wide range of IV catheter products to support patient care throughout the surgical process. Thus, the increasing number of surgical procedures enables the market to grow at a CAGR of 8.78% from 2024 to 2031.

IV (Intravascular) Catheter MarketDefinition/ Overview

An intravenous (IV) catheter is a slender, flexible tube inserted into a vein to facilitate the direct delivery of fluids, medications, or blood products into the bloodstream. This essential medical device is widely utilized across various healthcare settings, including hospitals, clinics, and home care environments, to provide swift and effective treatment for a range of medical conditions.

IV catheters offer a direct and efficient route for administering therapeutic substances, bypassing the digestive system. This method is particularly advantageous for patients who are unable to consume food or fluids orally due to medical conditions, or when there is a need for rapid medication delivery. By ensuring that medications and nutrients are introduced directly into the bloodstream, IV catheters enable precise and immediate therapeutic effects, which is crucial for managing acute conditions and supporting ongoing treatments.

In addition to their use in hospital and clinical environments, IV catheters are increasingly employed in home care settings, where they provide vital support for patients requiring continuous or intermittent treatments. The versatility and efficiency of IV therapy make it a cornerstone of modern medical practice, facilitating comprehensive patient care and enhancing treatment outcomes across diverse healthcare scenarios.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How the Rapid Technological Advancements and Innovations in the Healthcare Sector Surge the Growth of IV Catheters Market?

Rapid technological advancements and innovations in the medical sector surge the growth of IV catheters market. Recent developments include novel peripheral IV catheters, central venous catheters, and midline peripheral catheters, which are designed to efficiently administer fluids and medications directly into the patient’s bloodstream. Many of these catheters are coated with medications that are gradually released, helping to alleviate pain and reduce inflammation.

The market for central IV catheters is particularly dynamic, with ongoing innovations in tip design, material usage, and delivery mechanisms. Vendors are introducing advanced needles that can withstand high pressure and are compatible with power injectable systems. These improvements aim to enhance patient comfort and minimize the risk of bloodstream infections, driving market growth.

The rising demand for multi-lumen central venous catheters (CVCs) is a notable trend. Multi-lumen CVCs offer significant advantages for patients who require frequent intravenous medications, blood transfusions, laboratory tests, and parenteral nutrition. They reduce the need for multiple catheter insertions and lower the risk of infections, making them highly desirable. Vendors are increasingly focused on developing and offering these multi-lumen catheters to enhance efficiency and improve sales volume and profit margins.

Technological advancements also include the use of nanotechnology to enhance catheter materials. Nanoscale modifications improve biocompatibility and reduce thrombogenicity, which decreases the risk of clot formation. Additionally, integrating antimicrobial coatings on catheters helps prevent bacterial growth, reducing the incidence of catheter-related infections. Ultrasound technology is being employed to guide catheter insertion, which improves accuracy, reduces complications, and increases the success rate of procedures. These innovations collectively drive the growth of the global central IV catheter market, as they address key challenges and improve patient outcomes.

We're expecting to see a big jump in the need for intravenous catheters, and here's why. For starters, more and more IV catheters are getting the regulatory thumbs-up, which makes everyone feel better about using them and getting their hands on them. Plus, we're seeing more chronic illnesses like neurological, cardiovascular, and urological issues. This is especially true as our elderly population keeps growing, and they often need more medical care. And on top of all that, there's a growing understanding of how to prevent those nasty catheter-related bloodstream infections (CRBSI). Because everyone—doctors, nurses, and patients—is focused on keeping infections down and making sure folks are safe, we think we'll be seeing even more intravenous catheters used going forward.

How the Infection Risk Associated with the catheter bloodstream Impede the Growth of IV Catheter Market?

The risk of infection, such as catheter-related bloodstream infections (CRBSIs). These infections present significant challenges, prompting healthcare facilities to adopt stringent protocols to mitigate risks. However, these measures can increase operational complexities and overall costs, adding pressure to healthcare systems and manufacturers alike. Patient discomfort is another critical issue. The insertion and maintenance of IV catheters can cause pain and discomfort, which may lead to patient dissatisfaction. This discomfort can sometimes result in patients refusing treatment or discontinuing use, affecting the effectiveness and acceptance of IV therapy.

Product recalls pose a substantial risk as well. Any issues related to catheter quality, such as complications or manufacturing defects, can lead to recalls. Such incidents damage the reputation of manufacturers and undermine market confidence, potentially impacting sales and market dynamics. Cost pressures further complicate the landscape. The rising costs associated with advanced catheter technologies and the need for continual innovation can exert significant pressure on pricing and profitability for manufacturers. Balancing affordability with technological advancements remains a challenge in a cost-sensitive market.

Additionally, regulatory hurdles are a considerable restraint. The stringent regulatory requirements for device approval and market entry can extend development timelines and increase costs. Navigating these regulations requires substantial investment and resources, which can delay the introduction of new products and impact overall market growth.

Category-Wise Acumens

How the Low-Cost Therapy and Highly Favored Clinical Settings Surge the Growth of the Peripheral IV Catheter Segment?

The peripheral IV catheter segment significantly dominates the IV catheter market. Peripheral intravenous catheters (PIVCs) are increasingly favored in clinical settings for their ease of installation and removal, offering a more comfortable and minimally invasive option for obtaining intravenous therapy. This approach enhances patient satisfaction and proves to be more cost-effective compared to midline peripheral catheters and central venous catheters. The low cost of PIVCs, coupled with their user-friendly nature, positions them as a popular choice in various medical procedures.

The market for PIVCs is expected to experience growth driven by strategic initiatives from industry players, such as the introduction of innovative products, strategic partnerships, and mergers and acquisitions. This peripheral catheter significantly reduces the risk of needle stick injuries and blood exposure, contributing to safer intravenous access for healthcare providers.

Furthermore, the increasing preference for minimally invasive procedures is fueling the demand for PIVCs. These procedures are associated with shorter recovery times, reduced discomfort, and lower risk of complications, making them appealing for both patients and healthcare practitioners. PIVCs are commonly used to administer anesthetics and medications during such procedures, underscoring their importance in modern medical practices. As the adoption of minimally invasive techniques continues to rise, the demand for PIVCs is expected to grow, driven by their practical benefits and the ongoing evolution of medical technologies.

How do the Increasing Medical Procedures and Escalating Hospitalization Rates Foster the Growth Hospitals Pharmacies Segment?

The Hospital Pharmacies segment significantly dominates the IV Catheter Market. The global increase in hospitalization rates and the growing volume of medical procedures requiring IV fluid and solution infusion are major drivers of the IV catheter market. Hospitals remain the primary setting for IV catheter use, accounting for the majority of sales and continuing to dominate the market.

In these healthcare facilities, hospital pharmacies and stores play a crucial role in the distribution and storage of pharmaceuticals, including IV catheters. These on-site pharmacies manage a broad range of medications, from standard treatments to specialized and experimental drugs. As hospitals prioritize patient safety, there is a significant focus on minimizing the risks associated with IV catheter use, such as infections and complications.

In addition, to these concerns, hospitals are increasingly demanding IV catheters that feature advanced safety features. For instance, IV catheters with antimicrobial coatings are sought after for their ability to reduce infection risks, while needleless connectors are preferred for their role in minimizing needle-stick injuries and enhancing overall safety. This trend highlights the hospital’s commitment to improving patient outcomes and safety through the adoption of more sophisticated and safer catheter technologies.

Gain Access to IV (Intravascular) Catheter Market Report Methodology

Country/Region-wise Acumens

How do the Increasing Geriatric Population and the Extensive Network of Hospitals in the Region Surge the Growth of the IV (Intravascular) Catheter Market?

North America? Yeah, they basically own the IV catheter market. And it's not hard to see why. More and more people are dealing with chronic illnesses, and we've got a growing elderly population too – all needing IVs. Plus, you've got big players like Boston Scientific Corporation, BD, and Teleflex Incorporated, who are always coming up with new stuff and pushing the market forward. Think about ithospitals, clinics, ambulatory care centers... they're everywhere, and they all need IV catheters! So tons of patients have access to the intravenous treatments they need. Especially with more older folks around, who often need long-term IV therapy for their health issues. It’s all connected, you know?

Favorable government policies, heightened public awareness, and the presence of highly qualified medical professionals and renowned healthcare facilities further bolster the market’s expansion in North America. The high incidence of chronic diseases is anticipated to increase hospital admissions, which in turn will drive demand for vascular catheterization and vein access treatments. Innovations such as advanced biocompatible materials, antimicrobial coatings, and user-friendly designs are improving patient outcomes and driving market growth. These advancements contribute to safer, more effective catheterization processes, benefiting patients and healthcare providers.

Additionally, strategic initiatives by market players, including product innovations and various other activities, are contributing to the region’s market growth. North America is expected to hold the largest share of the intravascular catheters market during the forecast period, largely due to the increasing incidence of renal diseases. The increasing emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety. This focus has led to the development and adoption of advanced IV catheters equipped with features such as needleless connectors and antimicrobial coatings. Stringent regulations and guidelines surrounding infection control are propelling the market for these advanced safety-oriented products.

How the Increasing Investments in the Healthcare Sector and Growing Incidence of Chronic Conditions Foster the Growth of IV (Intravascular) Catheter Market?Bottom of Form

Spending on new and improved hospitals and clinics is really boosting the need for medical devices, especially IV catheters. Think about itnew hospitals, specialized centers, and upgrades to existing places all mean a greater demand for things like IV catheters to help doctors provide the best care. Plus, with more people dealing with chronic illnesses like diabetes, cancer, and heart problems, we're seeing a jump in the need for long-term IV therapy. And because IV catheters are so crucial for managing these conditions, their demand just keeps going up. Over in places like Japan and South Korea, the aging population is also a big factor. As more older folks need treatment for chronic illnesses, the need for IV catheters is really growing to meet their specific healthcare requirements.

As people have more money to spend, they're finding it easier to get healthcare and cutting-edge treatments. When your wallet's a bit fuller, you're more likely to look for top-notch medical care and maybe even splurge on things like advanced technologies, like IV catheters. That extra cash is really helping these kinds of medical devices become more common. Plus, the government's pitching in by backing improvements to hospitals and clinics and really pushing for patient safety. They've got programs designed to make healthcare more accessible, crack down on infections, and get those fancy medical gadgets into the hands of doctors and nurses. All this support is helping the IV catheter market grow, by making healthcare safer and smoother for everyone.

Competitive Landscape

The IV (Intravascular) catheter market is characterized by a mix of established global players and regional manufacturers. The industry is highly competitive, with companies focused on product innovation, cost-efficiency, and strong distribution networks.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the IV (Intravascular) catheter market include

  • BD (Becton, Dickinson, and Company)
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Smiths Medical
  • Medtronic
  • Abbott Laboratories
  • Edwards Lifesciences Corporation
  • Coloplast A/S
  • Stryker Corporation
  • Cook Medical
  • Merit Medical Systems, Inc.
  • Vygon
  • Nipro Corporation
  • Medsource Labs

Latest Developments

  • In October 2023, Linear Health Sciences announced that the Orchid SRV safety release valve had achieved US FDA approval. The device was approved for use with all IV access procedures; the catheter was designed to reduce the likelihood of IV catheter failure and repair in hospitals.
  • In April 2023, BD announced the Prevue II System, a completely innovative, user-friendly sophisticated ultrasound system with a tailored probe designed to assist surgeons in accurately implanting intravenous placements.
  • In September 2022, B. Braun SE announced the acquisition of Starboard Medical, Inc.’s cutting-edge Clik-FIX catheter protection device portfolio. With this acquisition, B. Braun added to its track record of creating new products and programs that improve patient outcomes and experiences with peripheral intravenous (IV) therapy.
  • In January 2022, ICU Medical, Inc. Smiths Medical announced the acquisition of Smiths Group plc. Smith’s Medical specializes in syringe and mobile infusion devices, vascular access, and critical care solutions.

Report Scope

Report AttributesDetails
Study Period

2021-2031

Growth Rate

CAGR of ~8.78% from 2024 to 2031

Base Year for Valuation

2024

Historical Period

2021-2023

Forecast Period

2024-2031

Quantitative Units

Value in USD Billion

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • Product Type
  • Material
  • End-User
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players

BD (Becton, Dickinson, and Company), Braun Melsungen AG, ICU Medical, Inc., Teleflex Incorporated, Terumo Corporation, Smiths Medical, Medtronic, Abbott Laboratories, Edwards Lifesciences Corporation, Coloplast A/S, Stryker Corporation, Cook Medical, Merit Medical Systems, Inc., Vygon, Nipro Corporation, Medsource Labs

Customization

Report customization along with purchase available upon request

IV (Intravascular) Catheter Market, By Category

Product Type

  • Peripheral IV Catheters
  • Central Venous Catheters (CVCs)
  • Midline Peripheral Catheters
  • Integrated/Closed IV Catheters

Material

  • Polyurethane IV Catheter
  • Silicone IV Catheters
  • Teflon IV Catheters

End-User

  • Hospitals Pharmacies
  • Retail Pharmacies

Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Related Reports

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email